Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Nora AI
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

RaySearch Laboratories: UMCG in the Netherlands purchases Micro-RayStation for pre-clinical research

Raysearch Laboratories

RaySearch Laboratories AB (publ) announces that University Medical Center Groningen (UMCG) in the Netherlands has placed an order for Micro-RayStation (μ-RayStation), RaySearch's research software platform for radiation treatment planning and plan evaluation in small animal irradiation research.

UMCG has been a RaySearch customer since 2013 and use RayStation as their main treatment planning system for external beam proton and photon radiotherapy. UMCG and RaySearch also have research collaborations together, and the center is part of the RayCare®* advisory board.

μ-RayStation combines the power of RayStation for patient modelling, visualization and general workflow including scripting with the accuracy of Monte Carlo dose calculation specifically tailored for small animal irradiation with x-rays and protons. UMCG will use μ-RayStation for research purposes at the Particle Therapy Research Center (PARTREC (https://umcgresearch.org/w/partrec)) irradiation facility under construction at UMCG.

Johan Löf, founder and CEO, RaySearch, says: "I am pleased that our long and successful collaboration with UMCG is now being extended to preclinical research. Together with the team at PARTREC, UMCG's new research facility, we look forward to continued research and development at the forefront."

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.